Overview / Abstract: |
Target Audience This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses, and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy. Program Overview This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy. Learning Objectives Upon completion of the program, attendees should be able to: Critically evaluate clinical data on current and emerging immune checkpoint inhibitors, with a focus on the unique type, incidence, and classification of immune-related adverse events (irAEs) across tumor types |
Expiration |
Jun 22, 2021 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Program Chairs Arjun V. Balar, MD Jeffrey S. Weber, MD, PhD FACULTY NAME and TITLE |
Keywords / Search Terms |
Relias LLC Relias LLC., Pan-Tumor, FREE CME. Free CE CME |